Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience

References

• Anastos, K., Lu, D., Shi, O., Mulligan, K., Tien, P. C., Freeman, R., … Hessol, N. A. (2007). The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antiviral Therapy, 12, 1049–1058.
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Santoro, N., & Schoenbaum, E. E. (2006). HIV infection and bone mineral density in middle-aged women. Clinical Infectious Diseases, 42, 1014–1020. doi:10.1086/501015
   PubMed Web of Science ®Google Scholar
• Bedimo, R., Adams-Huet, B., Poindexter, J., Farukhi, I., Castanon, R., Brown, G., … Maalouf, N. (2017). Bone microarchitectural changes and fracture-risk prediction in HIV and HCV. CROI Conference 2017, Seattle, Washington. Abstract number 677. Retrieved from http://www.croiconference.org/sessions/bone-microarchitectural-changes-and-fracture-risk-prediction-hiv-and-hcv
   Google Scholar
• Black, D. M., & Rosen, C. J. (2016). Clinical practice: Postmenopausal osteoporosis. New England Journal of Medicine, 374, 254–262. doi:10.1056/NEJMcp1513724
   PubMed Web of Science ®Google Scholar
• Bonfanti, P., Martinelli, C., Ricci, E., Carradori, S., Parruti, G., Armignacco, O., … T Quirino. (2005). An Italian approach to postmarketing monitoring: Preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir. Journal of Acquired Immune Deficiency Syndromes, 39, 317–320. doi:10.1097/01.qai.0000164248.56722.3c
   PubMed Web of Science ®Google Scholar
• Borderi, M., Gibellini, D., Vescini, F., De Crignis, E., Cimatti, L., Biagetti, C., … Re, M. C. (2009). Metabolic bone disease in HIV infection. AIDS, 23, 1297–1310. doi:10.1097/QAD.0b013e32832ce85a
   PubMed Web of Science ®Google Scholar
• Brown, T. T., Hoy, J., Borderi, M., Guaraldi, G., Renjifo, B., Vescini, F., … Powderly, W. G. (2015). Recommendations for evaluation and management of bone disease in HIV. Clinical Infectious Diseases, 60, 1242–1251. doi:10.1093/cid/civ010
   PubMed Web of Science ®Google Scholar
• Brown, T. T., & Qaqish, R. B. (2006). Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS, 20, 2165–2174. doi:10.1097/QAD.0b013e32801022eb
   PubMed Web of Science ®Google Scholar
• Centre for Metabolic Bone Diseases, University of Sheffield, UK. (2008). FRAX tool. Retrieved from http://www.sheffield.ac.uk/FRAX/tool.aspx?country=11
   Google Scholar
• Clò, A., Gibellini, D., Damiano, D., Vescini, F., Ponti, C., Morini, S., … Borderi, M. (2015). Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. New Microbiologica, 38, 345–356.
   PubMed Web of Science ®Google Scholar
• Collier, J. (2007). Bone disorders in chronic liver disease. Hepatology, 46, 1271–1278. doi:10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Cosman, F., De Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 25, 2359–2381. doi:10.1007/s00198-014-2794-2
   PubMed Web of Science ®Google Scholar
• Cournil, A., Eymard-Duvernay, S., Diouf, A., Moquet, C., Coutherut, J., Ngom, G. N. F., … Delaporte, E. (2012). Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal. PLoS One, 7, e31726. doi:10.1371/journal.pone.0031726
   PubMed Web of Science ®Google Scholar
• Dolan, S. E., Huang, J. S., Killilea, K. M., Sullivan, M. P., Aliabadi, N., & Grinspoon, S. (2004). Reduced bone density in HIV-infected women. AIDS, 18, 475–483. doi:10.1097/00002030-200402200-00014
   PubMed Web of Science ®Google Scholar
• Dong, H. V., Cortés, Y. I., & Shiau, S. (2014). Osteoporosis and fractures in HIV/hepatitis C virus coinfection: A systematic review and meta-analysis. AIDS, 28, 2119–2131. doi:10.1097/QAD.0000000000000363
   PubMed Web of Science ®Google Scholar
• EACS: European AIDS Clinical Society. (2015). Guidelines version 8.0. Retrieved from http://www.eacsociety.org/files/guidelines_8.0-english-revised_20160610.pdf
   Google Scholar
• El-Maouche, D., Mehta, S. H., Sutcliffe, C., Higgins, Y., Torbenson, M. S., Moore, R. D., … Brown, T. T. (2011). Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. Journal of Hepatology, 55, 770–776. doi:10.1016/j.jhep.2011.01.035
   PubMed Web of Science ®Google Scholar
• Fantauzzi, A., Floridia, M., Ceci, F., Cacciatore, F., Vullo, V., & Mezzaroma, I. (2016). Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: Comparison with dual X-ray absorptiometry. HIV/AIDS, 8, 109–117.
   Google Scholar
• Frost, M. L., Blake, G. M., & Fogelman, I. (1999). Contact quantitative ultrasound: An evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria. Osteoporosis International, 10, 441–449. doi:10.1007/s001980050252
   PubMed Web of Science ®Google Scholar
• Frost, M. L., Blake, G. M., & Fogelman, I. (2000). Does quantitative ultrasound imaging enhance precision and discrimination? Osteoporosis International, 11, 425–433. doi:10.1007/s001980070110
   PubMedGoogle Scholar
• Güerri-Fernández, R., Knobel, H., Villar, J., González-Mena, A., Guelar, A., Humbert, L., … Díez-Pérez, A. Bone density, microarchitecture, and bone strength after 1 year of TDF. CROI conference 2017, Seattle, Washington. Abstract number 681. Retrieved from http://www.croiconference.org/sessions/bone-density-microarchitecture-and-bone-strength-after-1-year-tdf
   Google Scholar
• Hileman, C. O., Labbato, D. E., Storer, N. J., Tangpricha, V., & McComsey, G. A. (2014). Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS, 28, 1759–1767. doi:10.1097/QAD.0000000000000320
   PubMed Web of Science ®Google Scholar
• Hologic. (n.d.). Sahara clinical bone sonometer. Retrieved from http://www.alpha-imaging.com/files/document%20library/hologic/hologic%20brochures/hologic%20sahara%20brochure.pdf
   Google Scholar
• Istituto Superiore della Sanità (ISS). (2015). Comunicato stampa N° 7/2015: Fumo, situazione di stallo, non cala il numero di fumatori in Italia. Retrieved from http://www.iss.it/pres/index.php?id=1525&tipo=1
   Google Scholar
• Krieg, M. A., Barkmann, R., Gonnelli, S., Stewart, A., Bauer, D. C., Del Rio Barquero, L., … Hans, D. (2008). Quantitative ultrasound in the management of osteoporosis: The 2007 ISCD official positions. Journal of Clinical Densitometry, 11, 163–187. doi:10.1016/j.jocd.2007.12.011
   PubMed Web of Science ®Google Scholar
• Kwan Tat, S., Padrines, M., Théoleyre, S., Heymann, D., & Fortun, Y. (2004). IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine & Growth Factor Reviews, 15, 49–60. doi:10.1016/j.cytogfr.2003.10.005
   PubMed Web of Science ®Google Scholar
• Laugier, P., Droin, P., Laval-Jeantet, A. M., & Berger, G. (1997). In vitro assessment of the relationship between acoustic properties and bone mass density of the calcaneus by comparison of ultrasound parametric imaging and quantitative computed tomography. Bone, 20, 157–165. doi:10.1016/S8756-3282(96)00347-X
   PubMed Web of Science ®Google Scholar
• Maalouf, N. M., Zhang, S., Drechsler, H., Brown, G. R., Tebas, P., & Bedimo, R. (2013). Hepatitis C co-infection and severity of liver diseaseas risk factors for osteoporotic fractures among HIV-infected patients. Journal of Bone and Mineral Research, 28, 2577–2583. doi:10.1002/jbmr.1988
   PubMed Web of Science ®Google Scholar
• Madeddu, G., Spanu, A., Solinas, P., Babudieri, S., Calia, G. M., Lovigu, C., … Madeddu, G. (2015). Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients. European Review for Medical and Pharmacological Sciences, 19, 4576–4589.
   PubMed Web of Science ®Google Scholar
• Madeddu, G., Spanu, A., Solinas, P., Calia, G. M., Lovigu, C., Chessa, F., … Madeddu, G. (2004). Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 48, 39–48.
   PubMed Web of Science ®Google Scholar
• McComsey, G. A., Tebas, P., Shane, E., Yin, M. T., Overton, E. T., Huang, J. S., … Brown, T. T. (2010). Bone disease in HIV infection: A practical review and recommendations for HIV care providers. Clinical Infectious Diseases, 51, 937–946. doi:10.1086/652982
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. (2001). Osteoporosis prevention, diagnosis, and therapy. JAMA, 285, 785–795. doi:10.1001/jama.285.6.785
   PubMed Web of Science ®Google Scholar
• Onen, N. F., Overton, E. T., Seyfried, W., Stumm, E. R., Snell, M., Mondy, K., & Tebas, P. (2010). Aging and HIV infection: A comparison between older HIV-infected persons and the general population. HIV Clinical Trials, 11, 100–109. doi:10.1310/hct1102-100
   PubMed Web of Science ®Google Scholar
• Pinzone, M. R., Castronuovo, D., Di Gregorio, A., Celesia, B. M., Gussio, M., Borderi, M., … Nunnari, G. (2016). Heel quantitative ultrasound in HIV-infected patients: A cross-sectional study. Infection, 44, 197–203. doi:10.1007/s15010-015-0842-2
   PubMed Web of Science ®Google Scholar
• Prior, J., Burdge, D., Maan, E., Milner, R., Hankins, C., Klein, M., & Walmsley, S. (2007). Fragility fractures and bone mineral density in HIV positive women: A case-control population-based study. Osteoporosis International, 18, 1345–1353. doi:10.1007/s00198-007-0428-7
   PubMed Web of Science ®Google Scholar
• Teichmann, J., Stephan, E., Lange, U., Discher, T., Friese, G., Lohmeyer, J., … Bretzel, R. G. (2003). Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. Journal of Infection, 46, 221–227. doi:10.1053/jinf.2002.1109
   PubMed Web of Science ®Google Scholar
• Tinago, W., Cotter, A. G., Sabin, C. A., Macken, A., Kavanagh, E., Brady, J. J., … Mallon, P. W. (2017). Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients. AIDS, 31, 643–652. doi:10.1097/QAD.0000000000001372
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008). Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. The Journal of Clinical Endocrinology and Metabolism, 93, 3499–3504. doi:10.1210/jc.2008-0828
   PubMed Web of Science ®Google Scholar
• Villa, P., Lassandro, A. P., Moruzzi, M. C., Amar, I. D., Vacca, L., Di Nardo, F., … Scambia, G. (2016). A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: A pilot study on FRAX(®) and QUS tools advantages. Journal of Endocrinological Investigation, 39, 191–198. doi:10.1007/s40618-015-0341-4
   PubMed Web of Science ®Google Scholar
• Womack, J. A., Goulet, J. L., Gibert, C., Brandt, C. A., Skanderson, M., Gulanski, B., … Justice, A. C. (2013). Physiologic frailty and fragility fracture in HIV-infected male veterans. Clinical Infectious Diseases, 56, 1498–1504. doi:10.1093/cid/cit056
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO Study Group. World Health Organization Technical Report No. 843. Geneva, Switzerland: Author.
   Google Scholar
• World Health Organization (WHO). (2004). WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level: Summary meeting report, Brussels, Belgium, 5–7 May 2004. Retrieved from http://www.who.int/chp/topics/Osteoporosis.pdf
   Google Scholar
• Yin, M., Dobkin, J., Brudney, K., Becker, C., Zadel, J. L., Manandhar, M., … Shane, E. (2005). Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporosis International, 16, 1345–1352. doi:10.1007/s00198-005-1845-0
   PubMed Web of Science ®Google Scholar
• Yin, M. T., Lu, D., Cremers, S., Tien, P. C., Cohen, M. H., Shi, Q., … Anastos, K. (2010). Short-term bone loss in HIV-infected premenopausal women. Journal of Acquired Immune Deficiency Syndromes, 53, 202–208. doi:10.1097/QAI.0b013e3181bf6471
   PubMed Web of Science ®Google Scholar
• Yin, M. T., Zhang, C. A., McMahon, D. J., Ferris, D. C., Irani, D., Colon, I., … Shane, E. (2012). Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study. The Journal of Clinical Endocrinology and Metabolism, 97, 554–562. doi:10.1210/jc.2011-2197
   PubMed Web of Science ®Google Scholar
• Zenilman, J. M., Hook, E. W., Shepherd, M., Smith, P., Rompalo, A. M., & Celentano, D. D. (1994). Alcohol and other substance use in STD clinic patients: Relationships with STDs and prevalent HIV infection. Sexually Transmitted Diseases, 21, 220–225. doi:10.1097/00007435-199407000-00008
   PubMed Web of Science ®Google Scholar